October 7th 2026
As autoimmune thyroid testing grows, QC manufacturers face an increasing challenge to secure anti-TPO materials that combine reliable performance with consistent, long-term supply.
Native anti-TPO serum and plasma provide excellent clinical relevance, but high-titre material can be difficult to source. Engineered Human Fc anti-TPO antibodies offer an alternative route to greater consistency and scalable supply.
)
January 11th 2021
From the outset of the COVID-19 outbreak, testing for SARS-CoV-2 has been a priority. Initially just having a test for COVID-19 was a scientific success, enabled by the publication of the first viral genomic sequence in January 2020. Here we highlight some of the key testing events that have taken place, and their outcomes.
)